Baker Bros. Advisors as of March 31, 2018
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 114 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Incyte Corporation (INCY) | 24.2 | $2.9B | 34M | 83.33 | |
| Seattle Genetics | 22.0 | $2.6B | 50M | 52.34 | |
| Beigene (BGNE) | 8.3 | $979M | 5.8M | 168.00 | |
| Alexion Pharmaceuticals | 8.1 | $954M | 8.6M | 111.46 | |
| BioMarin Pharmaceutical (BMRN) | 5.2 | $615M | 7.6M | 81.07 | |
| ACADIA Pharmaceuticals (ACAD) | 5.2 | $612M | 27M | 22.47 | |
| Genomic Health | 3.7 | $432M | 14M | 31.29 | |
| Ascendis Pharma A S (ASND) | 1.6 | $186M | 2.8M | 65.40 | |
| Aquinox Pharmaceuticals | 1.3 | $154M | 11M | 14.08 | |
| Avexis | 1.2 | $144M | 1.2M | 123.58 | |
| Heron Therapeutics (HRTX) | 1.2 | $139M | 5.0M | 27.60 | |
| Dbv Technologies S A | 1.1 | $127M | 5.5M | 23.07 | |
| Ablynx Nv | 1.0 | $119M | 2.2M | 54.56 | |
| Sage Therapeutics (SAGE) | 0.9 | $104M | 647k | 161.07 | |
| Array BioPharma | 0.8 | $92M | 5.7M | 16.32 | |
| Spark Therapeutics | 0.8 | $92M | 1.4M | 66.59 | |
| Neurocrine Biosciences (NBIX) | 0.7 | $78M | 945k | 82.93 | |
| Mirati Therapeutics | 0.7 | $78M | 2.5M | 30.70 | |
| Argenx Se (ARGX) | 0.7 | $77M | 962k | 80.44 | |
| Madrigal Pharmaceuticals (MDGL) | 0.6 | $72M | 616k | 116.79 | |
| Idera Pharmaceuticals | 0.6 | $71M | 39M | 1.84 | |
| Amarin Corporation (AMRN) | 0.6 | $68M | 23M | 3.01 | |
| BioCryst Pharmaceuticals (BCRX) | 0.6 | $67M | 14M | 4.77 | |
| Erytech Pharma Sa | 0.6 | $65M | 3.1M | 21.00 | |
| Novavax Inc note 3.750% 2/0 | 0.5 | $62M | 89M | 0.70 | |
| Cerus Corporation (CERS) | 0.5 | $59M | 11M | 5.48 | |
| Cymabay Therapeutics | 0.4 | $51M | 3.9M | 12.99 | |
| Rhythm Pharmaceuticals (RYTM) | 0.3 | $41M | 2.0M | 19.90 | |
| Invitae (NVTAQ) | 0.3 | $39M | 8.4M | 4.69 | |
| Bluebird Bio (BLUE) | 0.3 | $34M | 200k | 170.75 | |
| Abeona Therapeutics | 0.3 | $31M | 2.2M | 14.35 | |
| Sangamo Biosciences (SGMO) | 0.3 | $31M | 1.6M | 19.00 | |
| Halozyme Therapeutics (HALO) | 0.3 | $31M | 1.6M | 19.59 | |
| Nektar Therapeutics (NKTR) | 0.2 | $29M | 275k | 106.26 | |
| Bellicum Pharma | 0.2 | $27M | 4.2M | 6.56 | |
| Exelixis (EXEL) | 0.2 | $26M | 1.2M | 22.15 | |
| Xencor (XNCR) | 0.2 | $26M | 872k | 29.98 | |
| Galapagos Nv- (GLPG) | 0.2 | $26M | 260k | 99.76 | |
| Menlo Therapeutics | 0.2 | $26M | 700k | 37.58 | |
| Gw Pharmaceuticals Plc ads | 0.2 | $25M | 222k | 112.67 | |
| Endocyte | 0.2 | $21M | 2.3M | 9.09 | |
| Aimmune Therapeutics | 0.2 | $22M | 674k | 31.83 | |
| Merus N V (MRUS) | 0.2 | $22M | 1.2M | 18.53 | |
| Progenics Pharmaceuticals | 0.1 | $17M | 2.3M | 7.46 | |
| Intellia Therapeutics (NTLA) | 0.1 | $18M | 834k | 21.09 | |
| Insmed (INSM) | 0.1 | $16M | 700k | 22.52 | |
| Myokardia | 0.1 | $14M | 290k | 48.80 | |
| Biomarin Pharma Inc convertible/ | 0.1 | $14M | 15M | 0.94 | |
| Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.1 | $13M | 12M | 1.03 | |
| Aerie Pharmaceuticals | 0.1 | $12M | 216k | 54.25 | |
| Uniqure Nv (QURE) | 0.1 | $12M | 500k | 23.50 | |
| Contrafect | 0.1 | $12M | 7.2M | 1.63 | |
| Aeglea Biotherapeutics | 0.1 | $11M | 1.1M | 9.92 | |
| Audentes Therapeutics | 0.1 | $12M | 393k | 30.05 | |
| Vanda Pharmaceuticals (VNDA) | 0.1 | $10M | 600k | 16.85 | |
| Achillion Pharmaceuticals | 0.1 | $11M | 2.9M | 3.71 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.1 | $11M | 4.4M | 2.39 | |
| Corsicanto Ii Designated Act note | 0.1 | $11M | 10M | 1.10 | |
| Rigel Pharmaceuticals | 0.1 | $8.9M | 2.5M | 3.54 | |
| Macrogenics (MGNX) | 0.1 | $9.2M | 364k | 25.16 | |
| Glycomimetics (GLYC) | 0.1 | $9.1M | 563k | 16.23 | |
| Assembly Biosciences | 0.1 | $9.5M | 194k | 49.14 | |
| Anaptysbio Inc Common (ANAB) | 0.1 | $9.5M | 91k | 104.08 | |
| Foamix Pharmaceuticals | 0.1 | $8.2M | 1.6M | 5.13 | |
| Albireo Pharma | 0.1 | $8.1M | 250k | 32.57 | |
| Aevi Genomic | 0.1 | $8.2M | 4.1M | 2.01 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 0.1 | $7.2M | 9.5M | 0.76 | |
| Syros Pharmaceuticals | 0.1 | $7.5M | 575k | 12.98 | |
| Momenta Pharmaceuticals | 0.1 | $5.6M | 309k | 18.15 | |
| Alkermes (ALKS) | 0.1 | $5.8M | 100k | 57.96 | |
| Chemocentryx | 0.1 | $5.6M | 414k | 13.60 | |
| Acceleron Pharma | 0.1 | $6.4M | 164k | 39.10 | |
| Spring Bk Pharmaceuticals In | 0.1 | $5.7M | 373k | 15.38 | |
| G1 Therapeutics | 0.1 | $6.3M | 170k | 37.05 | |
| Inflarx Nv (IFRX) | 0.1 | $5.8M | 200k | 28.84 | |
| Novavax | 0.0 | $4.2M | 2.0M | 2.10 | |
| D Stemline Therapeutics | 0.0 | $4.4M | 288k | 15.30 | |
| La Jolla Pharmaceuticl Com Par | 0.0 | $4.6M | 155k | 29.78 | |
| Inotek Pharmaceuticals 5.75% Cb 08/01/2021-registe bond | 0.0 | $4.8M | 5.0M | 0.96 | |
| Nabriva Therapeutics | 0.0 | $4.7M | 938k | 5.03 | |
| Solid Biosciences | 0.0 | $4.4M | 588k | 7.50 | |
| Newlink Genetics Corporation | 0.0 | $3.7M | 507k | 7.25 | |
| Adamas Pharmaceuticals | 0.0 | $4.1M | 173k | 23.90 | |
| Corbus Pharmaceuticals Hldgs | 0.0 | $4.0M | 661k | 6.10 | |
| Clementia | 0.0 | $3.8M | 250k | 15.15 | |
| Tetraphase Pharmaceuticals | 0.0 | $2.9M | 935k | 3.07 | |
| Versartis | 0.0 | $2.4M | 1.4M | 1.65 | |
| Trillium Therapeutics, Inc. Cmn | 0.0 | $2.9M | 409k | 7.20 | |
| Natera (NTRA) | 0.0 | $2.1M | 229k | 9.27 | |
| Tonix Pharmaceuticals Hldg C | 0.0 | $2.1M | 700k | 3.00 | |
| Jounce Therapeutics | 0.0 | $2.2M | 100k | 22.35 | |
| Krystal Biotech (KRYS) | 0.0 | $2.0M | 200k | 10.09 | |
| Infinity Pharmaceuticals (INFIQ) | 0.0 | $1.2M | 580k | 2.10 | |
| Trevena | 0.0 | $1.6M | 950k | 1.64 | |
| Mediwound Ltd cmn | 0.0 | $1.2M | 226k | 5.20 | |
| T2 Biosystems | 0.0 | $649k | 100k | 6.49 | |
| Affimed Therapeutics B V | 0.0 | $740k | 400k | 1.85 | |
| Dynavax Technologies (DVAX) | 0.0 | $1.5M | 75k | 19.85 | |
| Proteon Therapeutics | 0.0 | $747k | 299k | 2.50 | |
| Cellectis S A (CLLS) | 0.0 | $1.6M | 50k | 31.52 | |
| Adaptimmune Therapeutics (ADAP) | 0.0 | $1.1M | 100k | 11.23 | |
| Arbutus Biopharma (ABUS) | 0.0 | $903k | 181k | 5.00 | |
| Akari Therapeutics | 0.0 | $619k | 340k | 1.82 | |
| Selecta Biosciences | 0.0 | $955k | 94k | 10.19 | |
| Sunesis Pharmaceuticals Inc Ne | 0.0 | $1.5M | 557k | 2.72 | |
| Ra Pharmaceuticals | 0.0 | $945k | 178k | 5.31 | |
| Ovid Therapeutics (OVID) | 0.0 | $1.8M | 248k | 7.07 | |
| Ritter Pharmaceuticals | 0.0 | $762k | 280k | 2.72 | |
| BioDelivery Sciences International | 0.0 | $473k | 210k | 2.25 | |
| Cyclacel Pharmaceuticals Inc pfd conv ex 6% (CYCCP) | 0.0 | $77k | 13k | 5.81 | |
| Immune Design | 0.0 | $492k | 149k | 3.30 | |
| Biotime Inc wts oct 1 18 | 0.0 | $2.0k | 20k | 0.10 | |
| Fulgent Genetics (FLGT) | 0.0 | $500k | 125k | 4.00 | |
| Molecular Templates | 0.0 | $579k | 72k | 8.00 |
